UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID): Molecular Pathogenesis and Clinical Manifestations

Bradford, KL; Moretti, FA; Carbonaro-Sarracino, DA; Gaspar, HB; Kohn, DB; (2017) Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID): Molecular Pathogenesis and Clinical Manifestations. Journal of Clinical Immunology , 37 (7) pp. 626-637. 10.1007/s10875-017-0433-3. Green open access

[thumbnail of Gaspar_revision 2 HBG_KLB.pdf]
Preview
Text
Gaspar_revision 2 HBG_KLB.pdf - Accepted Version

Download (342kB) | Preview

Abstract

Deficiency of adenosine deaminase (ADA, EC3.5.4.4), a housekeeping enzyme of purine metabolism encoded by the Ada gene, is a cause of human severe combined immune deficiency (SCID). Numerous deleterious mutations occurring in the ADA gene have been found in patients with profound lymphopenia (T(-) B(-) NK(-)), thus underscoring the importance of functional purine metabolism for the development of the immune defense. While untreated ADA SCID is a fatal disorder, there are multiple life-saving therapeutic modalities to restore ADA activity and reconstitute protective immunity, including enzyme replacement therapy (ERT), allogeneic hematopoietic stem cell transplantation (HSCT) and gene therapy (GT) with autologous gene-corrected hematopoietic stem cells (HSC). We review the pathogenic mechanisms and clinical manifestations of ADA SCID.

Type: Article
Title: Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID): Molecular Pathogenesis and Clinical Manifestations
Location: Netherlands
Open access status: An open access version is available from UCL Discovery
DOI: 10.1007/s10875-017-0433-3
Publisher version: http://doi.org/10.1007/s10875-017-0433-3
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Adenosine Deaminase, Clinical trials, Gene therapy, Lymphopenia, Purine metabolism, SCID
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
URI: https://discovery.ucl.ac.uk/id/eprint/1573199
Downloads since deposit
Loading...
1,396Downloads
Download activity - last month
Loading...
Download activity - last 12 months
Loading...
Downloads by country - last 12 months
Loading...

Archive Staff Only

View Item View Item